Research & Development



  果然是想多了,陸昔年鄙視自己。   “因為不喜歡運動?”林徵羽問。热热色琪琪热影音先锋   楊禮沒哭,在眼圈里打轉的淚花被他硬生生憋回去。全国最大色情成人网站   “忽略黑子,為什麼我總覺得Lin神在說到打電話的時候心情很好的樣子?”   林徵羽︰【喝茶】嫉妒使你丑陋。av天堂2018在线观看   陸昔年倒是沒想歪,因為他在看到林徵羽的時候就愣住了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo